Visit the Liberty Health Sciences Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Liberty Health Sciences Inc. Confirms No Structural Damage to Florida Facility Following Hurricane Irma
Liberty contributing 10 per cent of revenues to Red Cross; Expansion plans still on track
TORONTO, Sept. 11, 2017 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCBB: SCQBF) (“Liberty” or the “Company”) announced today that there is no structural damage to its facility in Alachua, Florida as a result of Hurricane Irma. In addition, no part of Liberty’s production process was affected, nor were any plants or inventories damaged because of the storm. All business operations have resumed with the exception of deliveries to our patients, which will recommence as soon as it is safe to do so.
Our hearts go out to all those affected by the devastation caused by Hurricane Irma and we are committed to providing support to ensure that local residents, including our employees, stay safe. Also, Liberty is proud to be a positive force in the community and to help with the relief efforts across the State of Florida, we are committing to contributing 10 per cent of revenues for two months to support the incredible relief efforts being undertaken by the Red Cross.
George Scorsis, CEO and Director of Liberty
A tropical storm warning remains in effect for Alachua, Florida for the next 24 hours and Liberty will provide further updates as events warrant.
Despite the storm, Liberty’s previously announced Part II expansion plans for the Alachua facility remain on track. This expansion will increase Liberty’s annual medical cannabis production to 2,800kgs by January 2018.
For more information on Liberty please visit www.libertyhealthsciences.com
About Liberty Health Sciences Inc.
Liberty Health Sciences Inc. (“Liberty”) is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal. Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.
The most reliable, fact-based information on Liberty Health Sciences found only on its Investor Dashboard.
Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.